Molecular engineering of the antitumor immune response

Bone Marrow Transplant. 1992:9 Suppl 1:182-6.

Authors

D M Pardoll¹, P Golumbek, H Levitsky, L Jaffee

Affiliation

¹ Dept. of Oncology, Medicine and Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

PMID: 1387016

No abstract available

Publication types

Review

MeSH terms

Animals
Antigen-Presenting Cells / immunology
Antigens, Neoplasm / immunology*
Genetic Therapy*
Immunologic Factors / administration & dosage
Immunologic Factors / genetics
Immunologic Factors / therapeutic use*
Immunotherapy*
Lymphokines / administration & dosage
Lymphokines / genetics
Lymphokines / therapeutic use*
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Neoplasms, Experimental / immunology*
Neoplasms, Experimental / therapy
Recombinant Proteins / administration & dosage
Recombinant Proteins / genetics
Recombinant Proteins / therapeutic use*
T-Lymphocytes, Cytotoxic / immunology
T-Lymphocytes, Helper-Inducer / immunology
Transfection
Tumor Cells, Cultured / metabolism
Tumor Cells, Cultured / transplantation

Substances

Antigens, Neoplasm
Immunologic Factors
Lymphokines
Recombinant Proteins